Memorial Şişli Hospital
| トルコ | オーストリア | スペイン | |
| 大腸癌に対する放射線療法 | から $7,000 | から $12,000 | から $10,000 |
| 乳癌化学療法 | から $1,200 | から $15,000 | から $3,500 |
Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.
Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.
イェシム・ユルドゥルム教授は、アナドル医療センターにてがん免疫療法および分子標的療法を専門としています。
Turkey is a primary destination for Wilms tumor treatment due to JCI-accredited hospitals and immediate access to care. Specialized centers provide comprehensive diagnostic protocols like scintigraphy. Families benefit from surgical oncology experts trained at leading international institutions. High-quality pediatric cancer care remains accessible without long waiting lists.
Bookimed Expert Insight: A major differentiator in Turkish oncology is the partnership with global leaders. For example, Anadolu Medical Center is affiliated with Johns Hopkins Hospital. This ensures pediatric protocols align with top US standards while maintaining the efficiency of private Istanbul centers. This synergy often results in a 90% success rate for complex transplant-related procedures.
Patient Consensus: Parents find that having a dedicated coordinator and airport pickup reduces the immense stress of a child's diagnosis. Many choose Turkey for a second opinion to verify staging before starting surgery or chemotherapy.
Turkish oncology centers report an 81.2% overall survival rate for Wilms tumor. Specialized facilities achieve success rates exceeding 90% for early-stage cases. Treatment involves multidisciplinary care. This includes surgery and chemotherapy. Leading hospitals maintain Joint Commission International accreditation for pediatric cancer protocols.
Bookimed Expert Insight: Success rates in Turkey are high because top centers mirror US protocols. Anadolu Medical Center is affiliated with Johns Hopkins Hospital. This connection ensures patients receive advanced oncology care. Most patients choose Istanbul centers. These hospitals serve over 65,000 international patients annually. This high volume builds significant surgical expertise in rare pediatric tumors.
Patient Consensus: Parents found the diagnostic process very thorough and fast. They appreciated that specialists explained every step of the complex treatment clearly.
The multidisciplinary plan for Wilms tumor involves pediatric oncologists, surgeons, and radiation specialists coordinating care. Treatment typically follows SIOP or COG protocols. These combine surgical nephrectomy with risk-stratified chemotherapy. Some cases require targeted radiation. This comprehensive approach yields 90% survival rates for localized cases.
Bookimed Expert Insight: Turkish oncology centers like Memorial Göztepe utilize multidisciplinary tumor boards for immediate case review. These boards often include surgeons like Dr. Murat Cakar who specializes in intra-abdominal cancer. This collaborative setting at JCI-accredited facilities ensures patients receive tailored plans combining surgery and systemic therapy.
Patient Consensus: Patients note it is important that all doctors are in one building. They feel more secure when the oncologists and surgeons work closely together.
Wilms tumor treatment in Turkey generally spans 3 to 12 months depending on the stage and pathology. A standard course includes diagnostic workups, surgical resection, and several chemotherapy cycles. Complex cases involving bilateral disease or metastasis often require extended radiation and systemic therapy protocols.
Bookimed Expert Insight: While many believe pediatric surgery is the longest phase, data from clinics like Memorial Şişli shows recovery is relatively quick. The real duration depends on pathology results, which dictate if chemotherapy lasts 18 or 30+ weeks. Experts like Dr. Murat Cakar at İstinye University Liv Hospital Topkapı often manage these long-term surgical and oncological transitions within one facility.
Patient Consensus: Parents note that treatment feels longer than expected due to waiting for pathology reports and subsequent follow-up scans. They appreciate that coordinators stay in touch throughout the many months of recurring oncology visits.